Beijing Anzhen Hospital Clinical Trials
Sponsors / Beijing Anzhen Hospital
According to ClinicalTrials.gov, Beijing Anzhen Hospital has served as lead sponsor on 262 registered trials. Across the portfolio, 55 are in recruitment, 5 are active non-recruiting, and 52 have reached completion. 3 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. Across the portfolio, planned enrollment totals 10,769,884 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
262
Total Trials
55
Recruiting
5
Other Active
52
Completed
3
Terminated / Withdrawn
10,769,884
Total Enrollment
Termination reasons: Recruitment67% · Safety33%
Recent Terminations
- Acute Exacerbation of COPD"Difficulty in recruiting subjects"
- ESRD"Patient recruitment difficulties"
- Microcirculatory Perfusion"DSMB halted the study due to safety concerns."
Active Trials (5 total)
- NCT06274411
- NCT07352891
- NCT07490808
- NCT07466056
- NCT07468383
- NCT06871228
- NCT04398992
- NCT07403760
- NCT07336394
- NCT07353775
- NCT07367399
- NCT05941377
- NCT07357272
- NCT06842147
- NCT03783351
- Acute Ischemic Stroke PHASE4NCT07290751
- NCT07247864
- NCT07150559
- NCT06416657
- NCT06855537